214 related articles for article (PubMed ID: 27318443)
1. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
[TBL] [Abstract][Full Text] [Related]
5. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of mutations in the
Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
[TBL] [Abstract][Full Text] [Related]
7. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
8.
Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
[No Abstract] [Full Text] [Related]
9. Mutational screening of germline
Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
11. Next-generation sequencing-based method shows increased mutation detection sensitivity in an Indian retinoblastoma cohort.
Singh J; Mishra A; Pandian AJ; Mallipatna AC; Khetan V; Sripriya S; Kapoor S; Agarwal S; Sankaran S; Katragadda S; Veeramachaneni V; Hariharan R; Subramanian K; Mannan AU
Mol Vis; 2016; 22():1036-47. PubMed ID: 27582626
[TBL] [Abstract][Full Text] [Related]
12. Low-grade glioma: A rare second tumor in retinoblastoma survivors.
Dalvi N; Kleinerman RA; Epelman S; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2021 Feb; 68(2):e28770. PubMed ID: 33063942
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
14. Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications.
Gregersen PA; Urbak SF; Funding M; Overgaard J; Jensen UB; Alsner J
Acta Oncol; 2016; 55(4):412-7. PubMed ID: 26494512
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Retinoblastoma.
Mallipatna A; Marino M; Singh AD
Asia Pac J Ophthalmol (Phila); 2016; 5(4):260-4. PubMed ID: 27488068
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
17. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
18. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
19. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
Römer T; Temming P; Lohmann DR; Sturm D; von Deimling A; Sellhaus B; Mull M; Kontny U; Moser O
Pediatr Blood Cancer; 2019 May; 66(5):e27599. PubMed ID: 30604586
[TBL] [Abstract][Full Text] [Related]
20. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
